查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1867595

胰岛素笔：全球市占率和排名、总收入和需求预测（2025-2031年）

Insulin Pen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 96 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年全球胰岛素笔市场规模估计为60.13亿美元，预计到2031年将达到105.19亿美元，2025年至2031年的复合年增长率为8.2%。

本报告对近期关税调整和国际策略反制措施对胰岛素笔跨境产业布局、资本配置模式、区域经济相互依存关係和供应链重组的影响进行了全面评估。

胰岛素笔是一种携带式、剂量可控制的医疗设备，用于糖尿病患者皮下注射胰岛素。它通常由笔身和可更换的针头组成，为传统的管瓶和注射器注射方式提供了更方便的替代方案。胰岛素笔具有剂量精准、使用方便、方便携带、提高病患依从性等优点。胰岛素笔有一次性使用和可重复使用两种版本，通常与预填充药筒搭配使用，用于治疗第1型和第2型糖尿病。作为慢性病管理的重要工具，胰岛素笔正在加速全球胰岛素治疗的标准化和个人化进程。

随着全球糖尿病盛行率持续上升，慢性病管理日益受到重视，胰岛素笔市场作为提高治疗顺从性和简化给药方式的关键工具，正迅速扩张。领先的製药和医疗设备製造商正积极投资产品创新，包括智慧胰岛素笔和数位化整合系统，以加强病患与医疗服务提供者之间的即时协作。政府支持基层医疗机构（尤其是在医疗资源匮乏地区）提供标准化糖尿病照护的政策，也推​​动了市场渗透。

儘管技术不断进步，胰岛素笔产业仍面临许多挑战。在某些地区，有限的保险覆盖范围和高昂的自付费用仍然是推广应用的障碍。来自低成本学名药的竞争给品牌药带来了压力。此外，设备相容性和缺乏标准化耗材等问题也会限制其国际扩充性。全球扩张还需要解决监管差异，并建立稳健的供应链以降低营运风险。

终端使用者的需求正从被动治疗转向主动疾病管理。尤其年轻患者更倾向于智慧监测和远端支援。胰岛素笔正日益融入数位生态系统，与血糖监测仪和行动应用程式协同运作，协助连结为互联慢性病管理模式的转变。一次性胰岛素笔因其便利性，在医院和基层医疗机构中广泛应用。全球人口老化将推动对安全、易用且可追溯的胰岛素笔的需求，从而引领市场进入下一个发展阶段。

本报告旨在对全球胰岛素笔市场进行全面分析，重点关注总销售量、收入、价格、市场份额和主要企业的排名，并按地区/国家、类型和应用对胰岛素笔进行分析。

胰岛素笔市场规模、估计和预测以销售（千支）和收入（百万美元）为单位呈现，基准年为2024年，并包含2020年至2031年的历史数据和预测数据。报告采用定量和定性分析相结合的方法，帮助读者制定胰岛素笔业务和成长策略，评估市场竞争，分析自身在当前市场中的地位，并做出明智的商业决策。

市场区隔

公司

  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Embecta
  • MDT Group
  • Dongbao
  • Owen Mumford
  • Ganlee

按类型分類的细分市场

  • 可重复使用的胰岛素笔
  • 抛弃式胰岛素笔

应用领域

  • 医院
  • 诊所
  • 药局

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Insulin Pen was estimated to be worth US$ 6013 million in 2024 and is forecast to a readjusted size of US$ 10519 million by 2031 with a CAGR of 8.2% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Insulin Pen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

An insulin pen is a portable, dose-controlled medical device designed for subcutaneous insulin delivery in diabetes patients. Typically consisting of a pen body and a replaceable needle, it offers a user-friendly alternative to traditional vial-and-syringe methods. Insulin pens provide advantages such as accurate dosing, ease of use, portability, and enhanced patient adherence. They are available in both disposable and reusable forms and are commonly used with prefilled cartridges for Type 1 and Type 2 diabetes management. As an essential tool in chronic disease control, insulin pens are accelerating the standardization and personalization of insulin therapy worldwide.

With the global prevalence of diabetes rising steadily and chronic disease management gaining attention, insulin pens are experiencing rapid market growth as a key tool to improve treatment compliance and ease of administration. Leading pharmaceutical and medical device companies are actively investing in product innovation, including smart insulin pens and digitally integrated systems, to enhance real-time connectivity between patients and healthcare providers. Government policies supporting standardized diabetes care at the primary level are also expanding market penetration, particularly in underserved regions.

Despite technological advancements, several challenges remain in the insulin pen industry. In some regions, limited reimbursement coverage and high out-of-pocket costs still hinder widespread adoption. Price competition from low-cost generics is putting pressure on originator brands. Additionally, issues such as device compatibility and lack of standardized consumables may limit international scalability. Global expansion also requires navigating regulatory variations and building resilient supply chains to mitigate operational risks.

End-user demand is shifting from passive treatment to active disease management, especially among younger patients who prefer smart monitoring and remote support. Insulin pens are increasingly integrated into digital ecosystems alongside glucose meters and mobile apps, reinforcing the shift toward connected chronic care. Disposable pens, due to their convenience, are seeing rising adoption across hospitals and primary care settings. With global aging trends, demand will grow for insulin pens that offer safety, usability, and traceability, driving the next phase of market evolution.

This report aims to provide a comprehensive presentation of the global market for Insulin Pen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Pen by region & country, by Type, and by Application.

The Insulin Pen market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Pen.

Market Segmentation

By Company

  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Embecta
  • MDT Group
  • Dongbao
  • Owen Mumford
  • Ganlee

Segment by Type

  • Reusable Insulin Pen
  • Disposable Insulin Pen

Segment by Application

  • Hospitals
  • Clinics
  • The Chemist's Shops

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Insulin Pen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Insulin Pen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Insulin Pen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Insulin Pen Product Introduction
  • 1.2 Global Insulin Pen Market Size Forecast
    • 1.2.1 Global Insulin Pen Sales Value (2020-2031)
    • 1.2.2 Global Insulin Pen Sales Volume (2020-2031)
    • 1.2.3 Global Insulin Pen Sales Price (2020-2031)
  • 1.3 Insulin Pen Market Trends & Drivers
    • 1.3.1 Insulin Pen Industry Trends
    • 1.3.2 Insulin Pen Market Drivers & Opportunity
    • 1.3.3 Insulin Pen Market Challenges
    • 1.3.4 Insulin Pen Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Insulin Pen Players Revenue Ranking (2024)
  • 2.2 Global Insulin Pen Revenue by Company (2020-2025)
  • 2.3 Global Insulin Pen Players Sales Volume Ranking (2024)
  • 2.4 Global Insulin Pen Sales Volume by Company Players (2020-2025)
  • 2.5 Global Insulin Pen Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Insulin Pen Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Insulin Pen Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Insulin Pen
  • 2.9 Insulin Pen Market Competitive Analysis
    • 2.9.1 Insulin Pen Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Pen Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Pen as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Reusable Insulin Pen
    • 3.1.2 Disposable Insulin Pen
  • 3.2 Global Insulin Pen Sales Value by Type
    • 3.2.1 Global Insulin Pen Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Insulin Pen Sales Value, by Type (2020-2031)
    • 3.2.3 Global Insulin Pen Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Insulin Pen Sales Volume by Type
    • 3.3.1 Global Insulin Pen Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Insulin Pen Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Insulin Pen Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Insulin Pen Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Hospitals
    • 4.1.2 Clinics
    • 4.1.3 The Chemist's Shops
  • 4.2 Global Insulin Pen Sales Value by Application
    • 4.2.1 Global Insulin Pen Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Insulin Pen Sales Value, by Application (2020-2031)
    • 4.2.3 Global Insulin Pen Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Insulin Pen Sales Volume by Application
    • 4.3.1 Global Insulin Pen Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Insulin Pen Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Insulin Pen Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Insulin Pen Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Insulin Pen Sales Value by Region
    • 5.1.1 Global Insulin Pen Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Insulin Pen Sales Value by Region (2020-2025)
    • 5.1.3 Global Insulin Pen Sales Value by Region (2026-2031)
    • 5.1.4 Global Insulin Pen Sales Value by Region (%), (2020-2031)
  • 5.2 Global Insulin Pen Sales Volume by Region
    • 5.2.1 Global Insulin Pen Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Insulin Pen Sales Volume by Region (2020-2025)
    • 5.2.3 Global Insulin Pen Sales Volume by Region (2026-2031)
    • 5.2.4 Global Insulin Pen Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Insulin Pen Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Insulin Pen Sales Value, 2020-2031
    • 5.4.2 North America Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Insulin Pen Sales Value, 2020-2031
    • 5.5.2 Europe Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Insulin Pen Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Insulin Pen Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Insulin Pen Sales Value, 2020-2031
    • 5.7.2 South America Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Insulin Pen Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Insulin Pen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Insulin Pen Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Insulin Pen Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Insulin Pen Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Insulin Pen Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Insulin Pen Sales Value, 2020-2031
    • 6.3.2 United States Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Insulin Pen Sales Value, 2020-2031
    • 6.4.2 Europe Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Insulin Pen Sales Value, 2020-2031
    • 6.5.2 China Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Insulin Pen Sales Value, 2020-2031
    • 6.6.2 Japan Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Insulin Pen Sales Value, 2020-2031
    • 6.7.2 South Korea Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Insulin Pen Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Insulin Pen Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Insulin Pen Sales Value, 2020-2031
    • 6.9.2 India Insulin Pen Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Insulin Pen Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Novo Nordisk
    • 7.1.1 Novo Nordisk Company Information
    • 7.1.2 Novo Nordisk Introduction and Business Overview
    • 7.1.3 Novo Nordisk Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 Novo Nordisk Insulin Pen Product Offerings
    • 7.1.5 Novo Nordisk Recent Development
  • 7.2 Eli Lilly
    • 7.2.1 Eli Lilly Company Information
    • 7.2.2 Eli Lilly Introduction and Business Overview
    • 7.2.3 Eli Lilly Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 Eli Lilly Insulin Pen Product Offerings
    • 7.2.5 Eli Lilly Recent Development
  • 7.3 Sanofi
    • 7.3.1 Sanofi Company Information
    • 7.3.2 Sanofi Introduction and Business Overview
    • 7.3.3 Sanofi Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Sanofi Insulin Pen Product Offerings
    • 7.3.5 Sanofi Recent Development
  • 7.4 Embecta
    • 7.4.1 Embecta Company Information
    • 7.4.2 Embecta Introduction and Business Overview
    • 7.4.3 Embecta Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 Embecta Insulin Pen Product Offerings
    • 7.4.5 Embecta Recent Development
  • 7.5 MDT Group
    • 7.5.1 MDT Group Company Information
    • 7.5.2 MDT Group Introduction and Business Overview
    • 7.5.3 MDT Group Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 MDT Group Insulin Pen Product Offerings
    • 7.5.5 MDT Group Recent Development
  • 7.6 Dongbao
    • 7.6.1 Dongbao Company Information
    • 7.6.2 Dongbao Introduction and Business Overview
    • 7.6.3 Dongbao Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Dongbao Insulin Pen Product Offerings
    • 7.6.5 Dongbao Recent Development
  • 7.7 Owen Mumford
    • 7.7.1 Owen Mumford Company Information
    • 7.7.2 Owen Mumford Introduction and Business Overview
    • 7.7.3 Owen Mumford Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 Owen Mumford Insulin Pen Product Offerings
    • 7.7.5 Owen Mumford Recent Development
  • 7.8 Ganlee
    • 7.8.1 Ganlee Company Information
    • 7.8.2 Ganlee Introduction and Business Overview
    • 7.8.3 Ganlee Insulin Pen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Ganlee Insulin Pen Product Offerings
    • 7.8.5 Ganlee Recent Development

8 Industry Chain Analysis

  • 8.1 Insulin Pen Industrial Chain
  • 8.2 Insulin Pen Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Insulin Pen Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Insulin Pen Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Insulin Pen Market Trends
  • Table 2. Insulin Pen Market Drivers & Opportunity
  • Table 3. Insulin Pen Market Challenges
  • Table 4. Insulin Pen Market Restraints
  • Table 5. Global Insulin Pen Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Insulin Pen Revenue Market Share by Company (2020-2025)
  • Table 7. Global Insulin Pen Sales Volume by Company (2020-2025) & (K Units)
  • Table 8. Global Insulin Pen Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Insulin Pen Price by Company (2020-2025) & (US$/Unit)
  • Table 10. Key Manufacturers Insulin Pen Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Insulin Pen Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Insulin Pen
  • Table 13. Global Insulin Pen Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Pen as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Insulin Pen Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Insulin Pen Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Insulin Pen Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Insulin Pen Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Insulin Pen Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Insulin Pen Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
  • Table 22. Global Insulin Pen Sales Volume by Type (2020-2025) & (K Units)
  • Table 23. Global Insulin Pen Sales Volume by Type (2026-2031) & (K Units)
  • Table 24. Global Insulin Pen Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Insulin Pen Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Insulin Pen Price by Type (2020-2025) & (US$/Unit)
  • Table 27. Global Insulin Pen Price by Type (2026-2031) & (US$/Unit)
  • Table 28. Global Insulin Pen Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Insulin Pen Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Insulin Pen Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Insulin Pen Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Insulin Pen Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Insulin Pen Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
  • Table 34. Global Insulin Pen Sales Volume by Application (2020-2025) & (K Units)
  • Table 35. Global Insulin Pen Sales Volume by Application (2026-2031) & (K Units)
  • Table 36. Global Insulin Pen Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Insulin Pen Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Insulin Pen Price by Application (2020-2025) & (US$/Unit)
  • Table 39. Global Insulin Pen Price by Application (2026-2031) & (US$/Unit)
  • Table 40. Global Insulin Pen Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Insulin Pen Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Insulin Pen Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Insulin Pen Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Insulin Pen Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Insulin Pen Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
  • Table 46. Global Insulin Pen Sales Volume by Region (2020-2025) & (K Units)
  • Table 47. Global Insulin Pen Sales Volume by Region (2026-2031) & (K Units)
  • Table 48. Global Insulin Pen Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Insulin Pen Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Insulin Pen Average Price by Region (2020-2025) & (US$/Unit)
  • Table 51. Global Insulin Pen Average Price by Region (2026-2031) & (US$/Unit)
  • Table 52. Key Countries/Regions Insulin Pen Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Insulin Pen Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Insulin Pen Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Insulin Pen Sales Volume, (2020-2025) & (K Units)
  • Table 56. Key Countries/Regions Insulin Pen Sales Volume, (2026-2031) & (K Units)
  • Table 57. Novo Nordisk Company Information
  • Table 58. Novo Nordisk Introduction and Business Overview
  • Table 59. Novo Nordisk Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 60. Novo Nordisk Insulin Pen Product Offerings
  • Table 61. Novo Nordisk Recent Development
  • Table 62. Eli Lilly Company Information
  • Table 63. Eli Lilly Introduction and Business Overview
  • Table 64. Eli Lilly Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 65. Eli Lilly Insulin Pen Product Offerings
  • Table 66. Eli Lilly Recent Development
  • Table 67. Sanofi Company Information
  • Table 68. Sanofi Introduction and Business Overview
  • Table 69. Sanofi Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 70. Sanofi Insulin Pen Product Offerings
  • Table 71. Sanofi Recent Development
  • Table 72. Embecta Company Information
  • Table 73. Embecta Introduction and Business Overview
  • Table 74. Embecta Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 75. Embecta Insulin Pen Product Offerings
  • Table 76. Embecta Recent Development
  • Table 77. MDT Group Company Information
  • Table 78. MDT Group Introduction and Business Overview
  • Table 79. MDT Group Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 80. MDT Group Insulin Pen Product Offerings
  • Table 81. MDT Group Recent Development
  • Table 82. Dongbao Company Information
  • Table 83. Dongbao Introduction and Business Overview
  • Table 84. Dongbao Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 85. Dongbao Insulin Pen Product Offerings
  • Table 86. Dongbao Recent Development
  • Table 87. Owen Mumford Company Information
  • Table 88. Owen Mumford Introduction and Business Overview
  • Table 89. Owen Mumford Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 90. Owen Mumford Insulin Pen Product Offerings
  • Table 91. Owen Mumford Recent Development
  • Table 92. Ganlee Company Information
  • Table 93. Ganlee Introduction and Business Overview
  • Table 94. Ganlee Insulin Pen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
  • Table 95. Ganlee Insulin Pen Product Offerings
  • Table 96. Ganlee Recent Development
  • Table 97. Key Raw Materials Lists
  • Table 98. Raw Materials Key Suppliers Lists
  • Table 99. Insulin Pen Downstream Customers
  • Table 100. Insulin Pen Distributors List
  • Table 101. Research Programs/Design for This Report
  • Table 102. Key Data Information from Secondary Sources
  • Table 103. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Insulin Pen Product Picture
  • Figure 2. Global Insulin Pen Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Insulin Pen Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Insulin Pen Sales Volume (2020-2031) & (K Units)
  • Figure 5. Global Insulin Pen Sales Price (2020-2031) & (US$/Unit)
  • Figure 6. Insulin Pen Report Years Considered
  • Figure 7. Global Insulin Pen Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Insulin Pen Players Sales Volume Ranking (2024) & (K Units)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin Pen Revenue in 2024
  • Figure 10. Insulin Pen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Reusable Insulin Pen Picture
  • Figure 12. Disposable Insulin Pen Picture
  • Figure 13. Global Insulin Pen Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Insulin Pen Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Insulin Pen Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
  • Figure 16. Global Insulin Pen Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Insulin Pen Price by Type (2020-2031) & (US$/Unit)
  • Figure 18. Product Picture of Hospitals
  • Figure 19. Product Picture of Clinics
  • Figure 20. Product Picture of The Chemist's Shops
  • Figure 21. Global Insulin Pen Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Insulin Pen Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Insulin Pen Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
  • Figure 24. Global Insulin Pen Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Insulin Pen Price by Application (2020-2031) & (US$/Unit)
  • Figure 26. North America Insulin Pen Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Insulin Pen Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Insulin Pen Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Insulin Pen Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Insulin Pen Sales Volume (%), (2020-2031)
  • Figure 38. United States Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Insulin Pen Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Insulin Pen Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Insulin Pen Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Insulin Pen Industrial Chain
  • Figure 60. Insulin Pen Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed